Hypertension in the Developing World

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Citação
Koch, V. H.. Hypertension in the Developing World. In: . Pediatric Hypertension: Fifth Edition: SPRINGER INTERNATIONAL PUBLISHING, 2023. p.739-752.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Hypertension is a major global chronic noncommunicable disease (NCD). Despite continued efforts to establish public policies to ensure surveillance and monitoring, the absolute numbers of patients affected by hypertension in low- and middle-income countries are likely to grow, as economic improvement favors longer life expectancy. Increasing longevity provides longer periods of exposure to the risk factors of cardiovascular disease (CVD), resulting in a greater probability of clinical manifestation of CVD events, especially because of the lack of awareness and insufficient treatment of the affected individuals. The survivors of an economic transition period are more likely to present the phenotype of lower birth weight coupled with either stunting or a higher body mass index in childhood or adulthood, which appears to be associated with the highest risks of morbid cardiovascular, renal, and metabolic outcomes into adulthood. The combination of population-wide and individual interventions may save millions of lives and considerably reduce human suffering from NCDs. © Springer Nature Switzerland AG 2023.
Palavras-chave
Economic transition, Fetal origins of adult disease, Global disease burden, Hypertension, Low birth weight, Malnutrition, Middle- and low-income countries, Stunting
Referências
  1. Addo J., Smeeth L., Leon D.A., Hypertension in sub-Saharan Africa: A systematic review, Hypertension, 50, pp. 1012-1018, (2007)
  2. Armitage J.A., Khan I.Y., Taylor P.D., Nathanielsz P.W., Poston L., Developmental programming of the metabolic syndrome by maternal nutritional imbalance:How strong is the evidence from experimental models in mammals?, J Physiol, 561, pp. 355-377, (2004)
  3. Bagby S.P., Maternal nutrition, low nephron number, and hypertension in later life: Pathways of nutritional programming, J Nutr, 137, pp. 1066-1072, (2007)
  4. Barker D.J., Developmental origins of adult health and disease, J Epidemiol Community Health, 58, pp. 114-115, (2004)
  5. Barker D.J.P., Sir Richard doll lecture developmental origins of chronic disease, Public Health, 126, pp. 185-189, (2012)
  6. Barker D.J., Osmond C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales, Lancet, 1, pp. 1077-1081, (1986)
  7. Barker D.J., Osmond C., Golding J., Kuh D., Wadsworth M.E., Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease, BMJ, 298, pp. 564-567, (1989)
  8. Barker D.J., Osmond C., Law C.M., The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis, J Epidemiol Community Health, 43, pp. 237-240, (1989)
  9. Barker D.J., Osmond C., Winter P.D., Margetts B.M., Simmonds S.J., Weight in infancy and death from ischaemic heart disease, Lancet, 2, pp. 577-580, (1989)
  10. Barker D.J., Bull A.R., Osmond C., Simmonds S.J., Fetal and placental size and risk of hypertension in adult life, BMJ, 301, pp. 259-262, (1990)
  11. Barker D.J.P., Hales C.N., Fall C.H.D., Osmond C., Phipps K., Clark P.M.S., Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): Relation to reduced fetal growth, Diabetologia, 36, pp. 62-67, (1993)
  12. Barker D.J.P., Martyn C.N., Osmond C., Haleb C.N., Fall C.H.D., Growth in utero and serum cholesterol concentrations in adult life, BMJ, 307, pp. 1524-1527, (1993)
  13. Barker D.J., Eriksson J.G., Forsen T., Osmond C., Fetal origins of adult disease: Strength of effects and biological basis, Int J Epidemiol, 31, pp. 1235-1239, (2002)
  14. Barker D.J., Osmond C., Forsen T.J., Kajantie E., Eriksson J.G., Trajectories of growth among children who have coronary events as adults, N Engl J Med, 353, pp. 1802-1809, (2005)
  15. Bateson P., Barker D., Clutton-Brock T., Deb D., Foley R.A., Gluckman P., Godfrey K., Kirkwood T., Mirazon Lahr M., Macnamara J., Metcalfe N.B., Monaghan P., Spencer H.G., Sultan S.E., Developmental plasticity and human health, Nature, 430, 430, pp. 419-421, (2004)
  16. Bergvall N., Iliadou A., Johansson S., de Faire U., Kramer M.S., Pawitan Y., Pedersen N.L., Lichtenstein P., Cnattingius S., Genetic and shared environmental factors do not confound the association between birth weight and hypertension: A study among Swedish twins, Circulation, 115, pp. 2931-2938, (2007)
  17. Blanchette E., Flynn J.T., Implications of the 2017 AAP clinical practice guidelines for Management of Hypertension in children and adolescents: A review, Curr Hypertens Rep, 21, 5, (2019)
  18. Blencowe H., Krasevec J., de Onis M., Black R.E., An X., Stevens G.A., Et al., National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: A systematic analysis, Lancet Glob Health, 7, 7, pp. e849-e860, (2019)
  19. Boyko E.J., Proportion of type 2 diabetes cases resulting from impaired fetal growth, Diabetes Care, 23, pp. 1260-1264, (2000)
  20. Brook J.S., Whiteman M., Brook D.W., Transmission of risk factors across three generations, Psychol Rep, 85, pp. 227-241, (1999)
  21. Brouwers S., Sudano I., Kokubo Y., Sulaica E.M., Arterial hypertension, The Lancet, 398, 10296, pp. 249-261, (2021)
  22. Campese V.M., Parise M., Karubian F., Bigazzi R., Abnormal renal hemodynamics in black salt-sensitive patients with hypertension, Hypertension, 18, pp. 805-812, (1991)
  23. Celsi G., Kistner A., Aizman R., Eklof A.C., Ceccatelli S., de Santiago A., Jacobson S.H., Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring, Pediatr Res, 44, pp. 317-322, (1998)
  24. Chiolero A., Cachat F., Burnier M., Paccaud F., Bovet P., Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight, J Hypertens, 25, 11, pp. 2209-2217, (2007)
  25. Flynn J.T., Kaelber D.C., Baker-Smith C.M., Blowey D., Carroll A.E., Daniels S.R., de Ferranti S.D., Dionne J.M., Falkner B., Flinn S.K., Gidding S.S., Goodwin C., Leu M.G., Powers M.E., Rea C., Samuels J., Simasek M., Thaker V.V., Urbina E.M., Subcommittee on screening and management of high blood pressure in children, Pediatrics, 140, 3, (2017)
  26. Curhan G.C., Willett W.C., Rimm E.B., Spiegelman D., Ascherio A.L., Stampfer M.J., Birth weight and adult hypertension, diabetes mellitus, and obesity in US men, Circulation, 94, pp. 3246-3250, (1996)
  27. Eriksson J.G., Osmond C., Barker D.J., Pathways of infant and childhood growth that lead to type 2 diabetes, Diabetes Care, 26, pp. 3006-3010, (2003)
  28. Ezzati M., Obermeyer Z., Tzoulaki I., Mayosi B.M., Elliott P., Leon D.A., The contributions of risk factors and medical care to cardiovascular mortality trends, Nat Rev Cardiol, 12, 9, pp. 508-530, (2015)
  29. Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, pp. 1204-1222, (2019)
  30. Gilbert T., Lelievre-Pegorier M., Merlet-Benichou C., Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat, Pediatr Res, 30, pp. 450-456, (1991)
  31. Gluckman P.D., Hanson M.A., Living with the past:Evolution, development and patterns of disease, Science, 305, pp. 1733-1736, (2004)
  32. Gluckman P.D., Hanson M.A., Beedle A.S., Early life events and their consequences for later disease
  33. a life history and evolutionary perspective, Am J Hum Biol, 19, pp. 1-19, (2007)
  34. Godfrey K.M., Lillycrop K.A., Burdge G.C., Gluckman P.D., Hanson M.A., Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease, Pediatr Res, 61, 2, pp. 5R-10R, (2007)
  35. Hales C.N., Barker D.J., Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis, Diabetologia, 35, pp. 595-601, (1992)
  36. Hales C.N., Barker D.J.P., The thrifty phenotype hypothesis, Br Med Bull, 60, pp. 5-20, (2001)
  37. Non-communicable diseases
  38. Heard E., Martienssen R.A., Transgenerational epigenetic inheritance: Myths and mechanisms, Cell, 157, pp. 95-109, (2014)
  39. Hinchliffe S.A., Lynch M.R., Sargent P.H., Howard C.V., Van Velzen D., The effect of intrauterine growth retardation on the development of renal nephrons, Br J Obstet Gynaecol, 99, pp. 296-301, (1992)
  40. Horikoshi M., Beaumont R.N., Day F.R., Warrington N.M., Kooijman M.N., Fernandez-Tajes J., Et al., Genome-wide associations for birth weight and correlations with adult disease, Nature, 538, pp. 248-252, (2016)
  41. Hoy W.E., Hughson M.D., Singh G.R., Douglas-Denton R., Bertram J.F., Reduced nephron number and glomerulomegaly in Australian aborigines. A group at high risk for renal disease and hypertension, Kidney Int, 70, pp. 104-110, (2006)
  42. Jackson A.A., All that glitters. British Nutrition Foundation Annual Lecture, Nutr Bull, 25, pp. 11-24, (2000)
  43. Juhola J., Magnussen C.G., Berenson G.S., Et al., Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: The international childhood cardiovascular cohort consortium, Circulation, 128, 3, pp. 217-224, (2013)
  44. Juonala M., Viikari J.S., Raitakari O.T., Main findings from the prospective cardiovascular risk in young Finns study, Curr Opin Lipidol, 24, 1, pp. 57-64, (2013)
  45. Kajantie E., Osmond C., Barker D.J., Forsen T., Phillips D.I., Eriksson J.G., Size at birth as a predictor of mortality in adulthood: A follow-up of 350, 000 person-years, Int J Epidemiol, 34, pp. 655-663, (2005)
  46. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J., Global burden of hypertension:Analysis of worldwide data, Lancet, 365, pp. 217-223, (2005)
  47. Keijzer-Veen M.G., Schrevel M., Finken M.J., Dekker F.W., Nauta J., Hille E.T., Frolich M., van der Heijden B.J., Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation, J Am Soc Nephrol, 16, pp. 2762-2768, (2005)
  48. Kelishadi R., Farajian S., The protective effects of breastfeeding on chronic non-communicable diseases in adulthood: A review of evidence, Adv Biomed Res, 3, (2014)
  49. Keller G., Zimmer G., Mall G., Ritz E., Amann K., Nephron number in patients with primary hypertension, N Engl J Med, 348, pp. 101-108, (2003)
  50. Kelly R.K., Thomson R., Smith K.J., Dwyer T., Venn A., Magnussen C.G., Factors affecting tracking of blood pressure from childhood to adulthood: The childhood determinants of adult health study, J Pediatr, 167, 6, (2015)
  51. Koskinen J.S., Kyto V., Juonala M., Viikari J.S.A., Nevalainen J., Kahonen M., Lehtimaki T., Hutri-Kahonen N., Laitinen T., Tossavainen P., Jokinen E., Magnussen C.G., Raitakari O.T., Childhood risk factors and carotid atherosclerotic plaque in adulthood:The cardiovascular risk in young Finns study, Atherosclerosis, 293, pp. 18-25, (2020)
  52. Lackland D.T., Bendall H.E., Osmond C., Egan B.M., Barker D.J., Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States, Arch Intern Med, 160, pp. 1472-1476, (2000)
  53. Law C.M., de Swiet M., Osmond C., Fayers P.M., Barker D.J., Cruddas A.M., Fall C.H., Initiation of hypertension in utero and its amplification throughout life, BMJ, 306, pp. 24-27, (1993)
  54. Lelievre-Pegorier M., Vilar J., Ferrier M.L., Moreau E., Freund N., Gilbert T., Merlet-Benichou C., Mild vitamin a deficiency leads to inborn nephron deficit in the rat, Kidney Int, 54, pp. 1455-1462, (1998)
  55. Lucas A., Programming by early nutrition in man, Ciba Found Symp, 156, pp. 38-50, (1991)
  56. Lumey L.H., Stein A.D., Offspring birth weights after maternal intrauterine undernutrition: A comparison within sibships, Am J Epidemiol, 146, pp. 810-819, (1997)
  57. McMillen C., Robinson J.S., Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming, Physiol Rev, 85, pp. 571-633, (2005)
  58. McNiece K.L., Poffenbarger T.S., Turner J.L., Franco K.D., Sorof J.M., Portman R.J., Prevalence of hypertension and pre-hypertension among adolescents, J Pediatr, 150, 6, (2007)
  59. Mittal B.V., Singh A.K., Hypertension in the developing world: Challenges and opportunities, Am J Kidney Dis, 55, pp. 590-598, (2010)
  60. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants, Lancet, 398, 10304, pp. 957-980, (2021)
  61. Neel J.V., Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”?, Am J Hum Genet, 14, pp. 353-362, (1962)
  62. Ong M.-L., Lin X., Holbrook J.D., Measuring epigenetics as the mediator of gene/environment interactions in DOHaD, J Dev Orig Health Dis, 6, pp. 10-16, (2015)
  63. Painter R.C., Roseboom T.J., Bleker O.P., Prenatal exposure to the Dutch famine and disease in later life:An overview, Reprod Toxicol, 20, pp. 345-352, (2005)
  64. Pham T.D., MacLennan N.K., Chiu C.T., Laksana G.S., Hsu J.L., Lane R.H., Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the fullterm IUGR rat kidney, Am J Physiol Regul Integr Comp Physiol, 285, pp. R962-R970, (2003)
  65. Razak F., Anand S.S., Shannon H., Vuksan V., Davis B., Jacobs R., Teo K.K., McQueen M., Yusuf S., Defining obesity cut points in a multiethnic population, Circulation, 115, pp. 2111-2118, (2007)
  66. Singhal A., Cole T.J., Lucas A., Early nutrition in preterm infants and later blood pressure: Two cohorts after randomized trials, Lancet, 357, pp. 413-419, (2001)
  67. Singhal A., Fewtrell M., Cole T.J., Lucas A., Low nutrient intake and early growth for later insulin resistance in adolescents born preterm, Lancet, 361, pp. 1089-1097, (2003)
  68. Song P., Zhang Y., Yu J., Zha M., Zhu Y., Rahimi K., Rudan I., Global prevalence of hypertension in children: A systematic review and meta-analysis, JAMA Pediatr, 173, 12, pp. 1154-1163, (2019)
  69. Thoman E.B., Levine S., Hormonal and behavioral changes in the rat mother as a function of early experience treatments of the offspring, Physiol Behav, 5, pp. 1417-1421, (1970)
  70. Thrift A.G., Srikanth V., Fitzgerald S.M., Kalyanram K., Kartik K., Hoppe C.C., Walker K.Z., Evans R.G., Potential roles of high salt intake and maternal malnutrition in the development of hypertension in disadvantaged populations, Clin Exp Pharmacol Physiol, 37, pp. e78-e90, (2010)
  71. Tiago A.D., Samani N.J., Candy G.P., Brooksbank R., Libhaber E.N., Sareli P., Woodiwiss A.J., Norton G.R., Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension, Circulation, 106, pp. 1483-1487, (2002)
  72. Transforming our world: The 2030 agenda for sustainable development
  73. Uiterwaal C.S., Anthony S., Launer L.J., Witteman J.C., Trouwborst A.M., Hofman A., Grobbee D.E., Birth weight, growth, and blood pressure: An annual follow-up study of children aged 5 through 21 years, Hypertension, 30, 2, pp. 267-271, (1997)
  74. UNICEF-WHO low birthweight estimates: Levels and trends 2000-2015, (2019)
  75. Levels and trends in childhood malnutrition/World Bank Group Joint Child Malnutrition Estimates Key findings of the 2018 edition, (2018)
  76. Unwin N., Harland J., White M., Bhopal R., Winocour P., Stephenson P., Watson W., Turner C., Alberti K.G., Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK, J Epidemiol Community Health, 51, pp. 160-166, (1997)
  77. Vehaskari V.M., Aviles D.H., Manning J., Prenatal programming of adult hypertension in the rat, Kidney Int, 59, pp. 238-245, (2001)
  78. von Bonsdorff M.E., von Bonsdorff M.B., Martikainen J., Salonen M., Kajantie E., Kautiainen H., Eriksson J.G., Body size at birth and coronary heart diseaserelated hospital care in adult men - findings from the Helsinki Birth Cohort Study, Ann Med, 23, pp. 1-16, (2016)
  79. Waddington C.H., The strategy of the genes: A discussion of some aspects of theoretical biology, (1957)
  80. Wang Z., Wu Y., Zhao L., Li Y., Yang J., Zhou B., Trends in prevalence, awareness, treatment and control of hypertension in the middleaged population of China, 1992-1998, Hypertens Res, 27, pp. 703-709, (2004)
  81. West-Eberhard M.J., Developmental plasticity and evolution, (2003)
  82. Whelton P.K., Carey R.M., Aronow W.S., Casey D.E., Collins K.J., Dennison Himmelfarb C., Et al., ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, Hypertension, 71, 6, pp. 1269-1324, (2018)
  83. Whincup P., Cook D., Papacosta O., Walker M., Birth weight and blood pressure: Cross sectional and longitudinal relations in childhood, BMJ, 311, pp. 773-776, (1995)
  84. Wing M.R., Devaney J.M., Joffe M.M., Xie D., Feldman H.I., Dominic E.A., Et al., Chronic renal insufficiency cohort (CRIC) study. DNA methylation profile associated with rapid decline in kidney function: Findings from the CRIC study, Nephrol Dial Transplant, 29, pp. 864-872, (2014)
  85. Woods L.L., Ingelfinger J.R., Nyengaard J.R., Rasch R., Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats, Pediatr Res, 49, pp. 460-467, (2001)
  86. Global health risks:Mortality and burden of disease attributable to selected major risks, (2009)
  87. Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases, (2017)
  88. Yach D., The global burden of chronic disease:Overcoming impediments to prevention and control, JAMA, 291, pp. 2616-2622, (2004)